COVID-19 vaccines | Fortune

Skip to Content

NEW

A vastly improved search engine helps you find the latest on companies, business leaders, and news more easily.

SIGN IN

Health
A COVID-vaccine maker received $1.6 billion in Operation Warp Speed funding. It’s administered just 7,300 shots in the U.S.
By
Nicholas Gordon
August 9, 2022
Commentary
A U.S. monkeypox pandemic can be prevented. COVID-19 has shown us how
By
Ronald Williams
and
Mike Swinford
August 5, 2022
Health
Fauci has a stark warning for you: Get those COVID vaccines and boosters now, or you’re ‘going to get into trouble’
By
Chloe Taylor
August 4, 2022
Health
What is BA.4.6? The CDC is tracking a new COVID ‘variant of concern’ that’s overtaking earlier Omicron strains in at least 4 U.S. states
By
Nicholas Gordon
August 4, 2022
Commentary
Here come the Roarin’ 20s. Invest until it hurts
By
John DiLullo
August 2, 2022
Health
U.S. reaches $1.74 billion deal with Moderna for its Omicron-specific vaccine
By
Zeke Miller
and
The Associated Press
July 29, 2022
Commentary
Here’s what the pandemic really looks like in America’s medical deserts
By
Daniel Greenleaf
July 28, 2022
Health
Fauci calls BA.5 a ‘moving target’ that may subside by the time Omicron boosters are ready. Scientists are pushing for a universal COVID vaccine instead
By
Grady McGregor
July 28, 2022
Commentary
A global effort to stop the spread of COVID-19 in Africa is underway–and it starts with health care workers
By
Adar Poonawalla
July 27, 2022
Tech
Facebook considers relaxing COVID-19 misinformation policies
By
Chris Morris
July 26, 2022
Health
China just approved its first domestic anti-COVID pill, Azvudine, and is ready to produce 6.8 billion pills a year at half the price of Pfizer’s Paxlovid
By
Grady McGregor
July 26, 2022
Health
Pfizer’s anti-COVID pill — used by Biden — is expected to rake in $23.2 billion, but confusion and weak demand could cause supply glut
By
Chloe Taylor
July 25, 2022
Well
The Bill & Melinda Gates Foundation partly funded an Omicron variant study with a surprising conclusion about boosters
By
Christine Mui
July 21, 2022
Health
The U.S.’s woefully low COVID vaccination rate makes it Novavax’s most appealing market yet
By
Grady McGregor
July 20, 2022

1 - 14 of 1,226 results

1 - 14 of 1,226 results